Endocrinology Practice Questions

Q: In Thyrotoxicosis, which type of Periodic Paralysis is commonly associated?

Hypokalemic Periodic Paralysis. Explanation: Thyrotoxic Periodic Paralysis (TPP) is a rare but life-threatening complication of thyrotoxicosis, characterized by sudden episodes of muscle weakness and hypokalemia. 1. Why Hypokalemic Periodic Paralysis is correct: The underlying mechanism is an intracellular shift of potassium, rather than a total body deficit. Excess thyroid hormones increase the activity of the Na+/K+-ATPase pump, which drives potassium from the extracellular fluid into the muscle cells. This hyperpolarizes the muscle membrane, making it unexcitable and leading to flaccid paralysis. This is often triggered by high carbohydrate meals (which release insulin, further stimulating the Na+/K+ pump) [3] or strenuous exercise. 2. Why other options are incorrect: * Hyperkalemic Periodic Paralysis: This is a genetic channelopathy (SCN4A mutation) where attacks are triggered by *increased* serum potassium or fasting. It is not associated with thyroid dysfunction. * Normokalemic Periodic Paralysis: A rare variant of sodium channelopathies where potassium levels remain normal during attacks. It has no clinical link to thyrotoxicosis. * No Periodic Paralysis: Incorrect, as TPP is a well-recognized clinical entity, particularly prevalent in males of Asian descent. Clinical Pearls for NEET-PG: * Demographics: Most common in Asian males (Male:Female ratio is 20:1), despite hyperthyroidism being more common in females. * Diagnosis: Low serum potassium during an attack with low TSH and high T3/T4 [1]. Low urinary potassium excretion distinguishes it from renal losses. * Management: * Acute: Cautious potassium replacement (risk of rebound hyperkalemia). * Prophylaxis: Propranolol (non-selective beta-blocker) is the drug of choice as it antagonizes the effect of thyroid hormones on the Na/K+ pump [2]. * Definitive: Achieving a euthyroid state [2].

Q: Early morning hyperglycemia with increased blood glucose at 3:00 AM suggests:

Insufficient insulin. This question tests the ability to differentiate between the three primary causes of early morning hyperglycemia in diabetic patients. The key to the diagnosis lies in the **3:00 AM blood glucose reading**. ### **1. Why "Insufficient Insulin" is Correct** Early morning hyperglycemia with an **elevated** 3:00 AM glucose level indicates that the basal insulin dose administered the previous evening was inadequate to cover the body's needs throughout the night. Since glucose is high at 3:00 AM and continues to rise until morning, it reflects a simple deficiency of insulin (waning effect) [1]. ### **2. Why the Other Options are Incorrect** * **Dawn Phenomenon:** This is a physiological rise in blood glucose between 4:00 AM and 8:00 AM caused by the nocturnal surge of counter-regulatory hormones (Growth Hormone, Cortisol, and Glucagon). Crucially, in Dawn Phenomenon, the **3:00 AM glucose is normal or slightly elevated**, not low. * **Somogyi Effect:** This is **rebound hyperglycemia**. It occurs when excessive evening insulin causes hypoglycemia in the middle of the night (around 3:00 AM) [2]. The body responds by releasing stress hormones (epinephrine, glucagon) that cause a spike in morning glucose. In Somogyi effect, the **3:00 AM glucose must be low (<70 mg/dL)**. ### **3. Clinical Pearls for NEET-PG** * **The "3 AM Rule":** To distinguish these conditions, always check the 3:00 AM blood sugar [2]. * **Low at 3 AM:** Somogyi Effect (Management: Decrease evening insulin or add a bedtime snack). * **High/Normal at 3 AM:** Dawn Phenomenon or Insufficient Insulin (Management: Increase evening insulin). * **Dawn Phenomenon** is most common in Type 1 Diabetics during puberty due to high Growth Hormone levels. * **Management Summary:** If glucose is high at 3 AM, you need **more** insulin; if it is low at 3 AM, you need **less** insulin.

Q: What percentage of beta cell mass is destroyed when type 1 diabetes becomes evident?

80%. **Explanation:** Type 1 Diabetes Mellitus (T1DM) is characterized by the autoimmune destruction of pancreatic beta cells. The clinical onset of the disease (hyperglycemia and symptoms like polyuria/polydipsia) occurs only after a significant "honeymoon period" of subclinical destruction [1]. **Why 80% is correct:** The pancreas possesses a massive functional reserve. Clinical symptoms of diabetes typically manifest only when **80% to 90%** of the beta-cell mass has been irreversibly destroyed. At this threshold, the remaining insulin-producing cells can no longer maintain euglycemia, leading to absolute insulin deficiency. In many standardized exams and textbooks (like Harrison’s Principles of Internal Medicine), the threshold for symptomatic presentation is cited as approximately 80-90%. **Why other options are incorrect:** * **A (20%) & B (40%):** At these stages, the patient is usually asymptomatic. The body compensates for the minor loss through increased efficiency of remaining cells. * **C (60%):** While significant destruction has occurred, the functional reserve of the pancreas is still sufficient to prevent overt fasting hyperglycemia in most individuals. **High-Yield Clinical Pearls for NEET-PG:** * **Markers of Destruction:** The presence of islet cell antibodies (ICA), anti-GAD65, and anti-IA2 antibodies are markers of the autoimmune process before clinical onset [1]. * **The "Honeymoon Phase":** After the initial diagnosis and start of insulin, some patients experience a temporary recovery of the remaining beta cells, requiring very low doses of insulin. * **Genetic Association:** Strongest association is with **HLA-DR3 and HLA-DR4** [1]. * **C-Peptide:** In T1DM, C-peptide levels are low or undetectable, reflecting the loss of endogenous insulin production.

Q: What is the drug of choice for pain relief in diabetic neuropathy?

Pregabalin. **Explanation:** **Pregabalin** is currently considered the first-line drug of choice (DOC) for the management of painful diabetic peripheral neuropathy (DPN). It is an **alpha-2-delta ($\alpha_2\delta$) ligand** [1] that binds to voltage-gated calcium channels in the central nervous system, decreasing the release of excitatory neurotransmitters (like glutamate and substance P). It is preferred over other agents due to its superior pharmacokinetic profile, predictable linear absorption, and established efficacy in multiple randomized controlled trials. **Analysis of Options:** * **Pregabalin (Correct):** FDA-approved as a first-line treatment. It has a faster onset of action and higher bioavailability compared to Gabapentin. * **Gabapentin (Incorrect):** While also an $\alpha_2\delta$ ligand and highly effective, it requires frequent dosing and complex titration due to non-linear pharmacokinetics. It is often considered a first-line alternative but is second to Pregabalin in most recent guidelines (ADA/AAN). * **Lamotrigine (Incorrect):** This antiepileptic has shown inconsistent results in clinical trials for DPN and is not recommended as a primary treatment. * **Mexiletine (Incorrect):** An oral Class IB antiarrhythmic (sodium channel blocker). It is rarely used today due to its narrow therapeutic index and significant side effect profile. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line agents for DPN:** Pregabalin, Duloxetine (SNRI), and Gabapentin. 2. **Tricyclic Antidepressants (TCAs):** Amitriptyline is effective but should be avoided in elderly patients due to anticholinergic side effects and risk of orthostatic hypotension. 3. **Duloxetine:** Preferred if the patient has comorbid depression. 4. **Mechanism:** Both Pregabalin and Gabapentin do *not* bind to GABA receptors; they act solely on the $\alpha_2\delta$ subunit of calcium channels [1].

Q: Thyroxine levels are raised in:

Grave's disease. **Explanation:** **Correct Answer: D. Grave's Disease** Grave’s disease is an autoimmune disorder characterized by the production of **Thyroid Stimulating Immunoglobulins (TSI)** [1]. These antibodies act as agonists to the TSH receptors on the thyroid gland, leading to unregulated synthesis and secretion of thyroid hormones [2]. Consequently, serum levels of **Thyroxine (T4)** and Triiodothyronine (T3) are significantly elevated, while TSH is suppressed [3]. **Analysis of Incorrect Options:** * **A. Myxedema:** This term refers to severe, advanced hypothyroidism. In this state, the thyroid gland fails to produce adequate hormones, resulting in **decreased** thyroxine levels and elevated TSH [3]. * **B. Endemic Goitre:** Usually caused by dietary **iodine deficiency**, this condition leads to impaired hormone synthesis. While patients may remain euthyroid due to compensatory thyroid enlargement (goitre), thyroxine levels are typically low or low-normal, never raised. * **C. Idiopathic Nontoxic Colloid Goitre:** This is a form of diffuse enlargement of the thyroid gland without clinical or laboratory evidence of thyroid dysfunction. By definition, "nontoxic" implies that hormone levels (T3/T4) remain within the **normal range**. **High-Yield Clinical Pearls for NEET-PG:** * **Grave’s Triad:** Hyperthyroidism (Goitre), Exophthalmos (Ophthalmopathy), and Pretibial Myxedema (Dermopathy) [1]. * **Diagnosis:** Elevated Free T4, suppressed TSH, and diffuse uptake on Radioactive Iodine Uptake (RAIU) scan [2]. * **Antibody Marker:** Anti-TSH receptor antibodies (TRAb/TSI) are highly specific for Grave’s [1]. * **Treatment of Choice:** Antithyroid drugs (Methimazole/PTU) for medical management; Radioiodine ablation is often the definitive treatment in adults.

Q: Cushing's disease is characterized by:

Increased ACTH and increased cortisol. **Explanation:** **Cushing’s Disease** specifically refers to hypercortisolism caused by a **pituitary adenoma** (usually a microadenoma) that hypersecretes Adrenocorticotropic Hormone (ACTH) [1]. 1. **Why Option D is Correct:** In Cushing’s Disease, the primary pathology is in the anterior pituitary [1]. The adenoma secretes excessive **ACTH**, which then stimulates the adrenal cortex (zona fasciculata) to produce and release high levels of **cortisol** [2]. Unlike the normal physiological state, the pituitary tumor is relatively resistant to negative feedback, leading to the simultaneous elevation of both ACTH and cortisol. 2. **Why Other Options are Incorrect:** * **Option A:** ADH (Vasopressin) is related to water balance (Diabetes Insipidus or SIADH) and is not the primary hormone involved in Cushing’s pathology. * **Option B:** Increased urinary catecholamines are diagnostic for **Pheochromocytoma**, not Cushing’s. * **Option C:** Increased ACTH with decreased cortisol is seen in **Primary Adrenal Insufficiency (Addison’s Disease)**, where the pituitary tries to compensate for adrenal failure. **High-Yield Clinical Pearls for NEET-PG:** * **Cushing’s Syndrome vs. Disease:** "Syndrome" is the broad term for hypercortisolism of any cause (most common cause is exogenous steroids). "Disease" is specifically the pituitary cause [1]. * **Screening Tests:** Overnight Dexamethasone Suppression Test (ONDST) or 24-hour urinary free cortisol [3]. * **Gold Standard Localization:** Inferior Petrosal Sinus Sampling (IPSS) is used to differentiate a pituitary source from ectopic ACTH production (e.g., Small Cell Lung Cancer). * **Dexamethasone Suppression:** Cushing’s Disease usually shows suppression with **High-Dose** Dexamethasone, whereas ectopic ACTH and adrenal tumors do not.

Question 1

A patient presented with episodes of flushing and hypotension. His urinary 5HIAA levels were found to be increased. What is the diagnosis?

Accepted Answer

Carcinoid syndrome

Answer

Pheochromocytoma

Answer

Addison's disease

Answer

SIADH

Question 2

In Thyrotoxicosis, which type of Periodic Paralysis is commonly associated?

Accepted Answer

Hypokalemic Periodic Paralysis

Answer

Hyperkalemic Periodic Paralysis

Answer

Normokalemic Periodic Paralysis

Answer

No Periodic Paralysis

Question 3

Early morning hyperglycemia with increased blood glucose at 3:00 AM suggests:

Accepted Answer

Insufficient insulin

Answer

Dawn phenomenon

Answer

Somogyi effect

Answer

None of the above

Question 4

A 75-year-old female patient, who had a fracture of the neck of the femur 1 month ago, presents with a 2-day history of altered sensorium and decreased urine output. Her urea is 140 mg/dL, creatinine is 2 mg/dL, and calcium is 15.5 mg/dL. Which of the following will be useful in the immediate treatment, except?

Accepted Answer

Furosemide

Answer

Normal Saline (NS) infusion

Answer

Hemodialysis

Answer

Bisphosphonates

Question 5

What percentage of beta cell mass is destroyed when type 1 diabetes becomes evident?

Accepted Answer

80%

Answer

20%

Answer

40%

Answer

60%

Question 6

What is the drug of choice for pain relief in diabetic neuropathy?

Accepted Answer

Pregabalin

Answer

Gabapentin

Answer

Lamotrigine

Answer

Mexiletine

Question 7

In hyperosmolar hyperglycemic non-ketotic coma, what is the typical blood glucose level?

Accepted Answer

55 mmol/L

Answer

20 mmol/L

Answer

80 mmol/L

Answer

5 mmol/L

Question 8

Thyroxine levels are raised in:

Accepted Answer

Grave's disease

Answer

Myxedema

Answer

Endemic goitre

Answer

Idiopathic nontoxic colloid goitre

Question 9

Secondary hyperparathyroidism is seen in all of the following conditions EXCEPT:

Accepted Answer

Parathyroid adenoma

Answer

Chronic renal failure

Answer

Vitamin D deficiency

Answer

Medullary carcinoma thyroid

Question 10

Cushing's disease is characterized by:

Accepted Answer

Increased ACTH and increased cortisol

Answer

Increased ADH

Answer

Increased urinary catecholamines

Answer

Increased ACTH and decreased cortisol

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?